Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease
A Furumoto, Y Ohkusa, M Chen, K Kawakami… - Vaccine, 2008 - Elsevier
To determine the clinical efficacy of combined vaccination with 23-valent pneumococcal
vaccine (PV) and influenza vaccine (IV) against pneumonia and acute exacerbation of
chronic lung diseases (CLD), we conducted an open-label, randomized, controlled study
among 167 adults with CLD over a 2-year period. Subjects were randomly assigned to a
PV+ IV group (n= 87) or an IV group (n= 80). The number of patients with CLD experiencing
infectious acute exacerbation (P= 0.022), but not pneumonia (P= 0.284), was significantly …
vaccine (PV) and influenza vaccine (IV) against pneumonia and acute exacerbation of
chronic lung diseases (CLD), we conducted an open-label, randomized, controlled study
among 167 adults with CLD over a 2-year period. Subjects were randomly assigned to a
PV+ IV group (n= 87) or an IV group (n= 80). The number of patients with CLD experiencing
infectious acute exacerbation (P= 0.022), but not pneumonia (P= 0.284), was significantly …
[引用][C] Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease
古本朗嗣 - 2008 - ci.nii.ac.jp
以上显示的是最相近的搜索结果。 查看全部搜索结果